Filing Flows

Filing Flows › Merit Medical Systems (MMSI) › Recalls, complaints & regulation

Merit Medical Systems (MMSI): clinical trials

Merit Medical Systems (MMSI) beyond its filings: 8 active clinical trials.

Merit Medical Systems' latest quarter

Merit Medical Systems, Q3 2026: revenue $416M (+8% year over year), operating margin 14.1%, net earnings $42.3M, operating cash flow $65.3M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Merit Medical Systems have?

8 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.